Stereotaxis to Reveal Q1 2025 Financial Highlights
ST. LOUIS, April 22, 2025 – Stereotaxis (NYSE: STXS), a leader in surgical robotics focused on minimally invasive endovascular interventions, is gearing up to release its financial results for the first quarter of 2025. The announcement is scheduled for May 12, 2025, coinciding with the close of the U.S. financial markets.
Conference Call and Webcast Details
On the same day, at 4:30 p.m. ET, Stereotaxis will host a conference call to discuss its financial performance and key corporate developments. Investors and interested parties can dial in using two numbers: 800-715-9871 (U.S. and Canada) or 1-646-307-1963 (International). Participants will need to enter the pass code 4794777 to gain access to the live discussion.
Accessing the Live Webcast
Alive webcast of the conference will also be available, which can be accessed through the investor relations section of Stereotaxis' official website. This will provide an opportunity for shareholders and interested stakeholders to stay informed about the company's financial health and future direction.
Reviewing the Call Replay
For those unable to participate live, a phone replay of the call will be accessible approximately four hours after the conclusion of the event. The replay will be available for a month, ensuring that all interested parties can catch up on the key discussions and insights shared during the call.
About Stereotaxis
Stereotaxis is renowned for its cutting-edge robotic systems designed for minimally invasive interventions. The company continues to innovate, with a mission to enhance the safety, precision, and efficiency of surgical procedures. Stereotaxis technology has already benefited over 150,000 patients around the globe, showcasing its commitment to advancing healthcare through robotics.
By developing advanced instruments and information solutions for interventional labs, Stereotaxis enables healthcare providers to deliver superior patient care. With a focus on expanding access to minimally invasive therapies and improving operational productivity, Stereotaxis remains a pivotal entity in the evolution of surgical robotics.
Frequently Asked Questions
1. When will Stereotaxis announce its Q1 2025 financial results?
Stereotaxis will announce its Q1 2025 financial results on May 12, 2025, at the close of U.S. financial markets.
2. How can I listen to the conference call?
You can listen to the conference call by dialing 800-715-9871 (U.S. and Canada) or 1-646-307-1963 (International) and entering the pass code 4794777.
3. Is there a way to access the webcast after the live event?
Yes, a replay of the conference call will be available for one month following the event.
4. What is Stereotaxis known for?
Stereotaxis is known for pioneering surgical robotics that facilitate minimally invasive endovascular procedures, enhancing patient care significantly.
5. How many patients have benefited from Stereotaxis technology?
Over 150,000 patients have been treated using Stereotaxis technology globally.
